These data, showing a 23% risk reduction of a heart attack, stroke and death, fill an important gap and reinforce the well-established clinical evidence of semaglutide
While its benefits are well-documented, its effects on hormonal health, including menstrual cycles and reproductive function, are an area of ongoing research
Behavioral deviation from normal conditions was quantified by assessing the aggregate differences between features in the drug versus no-drug conditions
There have been postmarketing reports of renal impairment, acute kidney injury, and worsening of chronic renal failure, which sometimes has required hemodialysis, in patients treated with GLP-1 receptor agonists
Filing a lawsuit against a weight loss drug manufacturer can be a complicated and intimidating process, especially if you are still dealing with a health crisis caused by those drugs